Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardio Vascular Dynamics (CVD) to develop Facilitated Force Angioplasty:

This article was originally published in Clinica

Executive Summary

Endosonics subsidiary Cardio Vascular Dynamics (US) has licensed the exclusive, worldwide rights to Facilitated Force Angioplasty (FFA) technology which uses a novel catheter design for controlled incision of atherosclerotic plaque. The technology mechanically controls the scoring and cutting of artherosclerotic plaque so that conventional angioplasty can be carried out. The California-based company has agreed to finalise the development of FFA, complete clinical trials and obtain worldwide marketing approvals. FFA was developed by Dr Michael Stillabower, a practising interventional cardiologist at the Medical Center of Delaware, California.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel